Cassava Sciences

An Alzheimer’s drugmaker is accused of data ‘manipulation.’ Should its trials be stopped?
Pharma Voice
Fri, 10/4/24 - 09:19 am
Cassava Sciences
Alzheimer's disease
data manipulation
Cassava, former execs ink SEC deal to resolve allegations around misleading Alzheimer's data drop
Fierce Biotech
Mon, 09/30/24 - 09:23 am
Cassava Sciences
Alzheimer's disease
SEC
Cassava Execs Step Down Amid DOJ Probe of Possible Alzheimer’s Drug Fraud
BioSpace
Thu, 07/18/24 - 11:07 am
Cassava Sciences
DOJ
fraud
Alzheimer's disease
simufilam
Two Senior Cassava Employees Subjects in Federal Probes After Former Advisor Indicted for Fraud
BioSpace
Tue, 07/2/24 - 11:37 am
Cassava Sciences
Alzheimer's disease
legal
fraud
No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months
BioSpace
Thu, 02/8/24 - 10:57 am
Cassava Sciences
Alzheimer's disease
clinical trials
simufilam
Co-developer of Cassava’s potential Alzheimer’s drug cited for ‘egregious misconduct’
Science
Mon, 10/30/23 - 08:15 pm
Cassava Sciences
Alzheimer's disease
Simulfilam
clinical trials
Cassava Defends Alzheimer’s Asset in Response to Data Manipulation Allegations
BioSpace
Fri, 10/13/23 - 10:24 am
Cassava Sciences
Alzheimer's diseases
simufilam
clinical trials
Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease
BioSpace
Mon, 09/18/23 - 07:45 pm
Cassava Sciences
clinical trials
Simulfilam
Alzheimer's disease
Why Shares of Cassava Sciences Are Dropping Wednesday
Motley Fool
Wed, 07/5/23 - 07:01 pm
Cassava Sciences
simufilam
Alzheimer's disease
Why Shares of Cassava Sciences Jumped Last Week
Motley Fool
Mon, 05/15/23 - 10:10 am
Cassava Sciences
Simulfilam
oncology
cancer
Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s Disease
BioSpace
Tue, 01/24/23 - 10:25 am
Cassava Sciences
clinical trials
simufilam
Alzheimer's disease
Roche Failure Leaves Industry Reassessing Alzheimer's Space
BioSpace
Wed, 11/16/22 - 10:45 am
Roche
Alzheimer's disease
gantenerumab
Biogen
Cassava Sciences
Eli Lilly
No Evidence of Data Manipulation in Science Publication on Simufilam
BioSpace
Thu, 08/18/22 - 10:48 am
Cassava Sciences
Alzhimer's disease
Simulfilam
data manipulation
Cassava Sciences faces U.S. criminal probe tied to Alzheimer's drug, sources say
Reuters
Wed, 07/27/22 - 10:56 am
Cassava Sciences
DOJ
data manipulation
Alzheimer's disease
simufilam
Life Sciences Industry has Eyes on Texas' Innovation Corridor
BioSpace
Wed, 05/4/22 - 10:45 am
Texas
biotech hubs
life sciences
Fujifilm
BioBridge
Luminex
Vaxxinity
Veravas
Cassava Sciences
Cassava Faces Renewed Speculation Over Experimental Alzheimer’s Drug
BioSpace
Tue, 04/19/22 - 11:44 pm
Cassava Sciences
Alzheimer's disease
simufilam
Cassava 10K Filing Warns of Anticipated Hold, Paints Dire Picture of Alzheimer's Space
BioSpace
Thu, 03/3/22 - 10:23 am
Cassava Sciences
FDA
clinical trials
Alzheimer's disease
simufilam
Cassava scores a win as FDA declines to intervene in petition to stop its Alzheimer's drug trials
Fierce Biotech
Fri, 02/11/22 - 11:41 am
Cassava Sciences
FDA
clinical trials
Alzheimer's disease
simufilam
Where Will Cassava Sciences Be in 1 Year?
Motley Fool
Fri, 01/7/22 - 10:45 am
Cassava Sciences
Simulfilam
clinical trials
Alzheimer's disease
Cassava Sciences under SEC probe for manipulating Alzheimer’s drug data
Seeking Alpha
Wed, 11/17/21 - 10:45 am
Cassava Sciences
SEC
data manipulation
Alzheimer's disease

Pages